-
Type: PDF Pages: 18 Size: 680KB July 8, 2009New Transparency and New Trust
Bridging the Digital Divide in the FDA’s May 2009 Draft Guidance on Presenting Risk Information
What are the implications of the May 2009 FDA draft guidance on risk presentation on your digital marketing? Carlen Lea Lesser, Associate Director for Interactive Strategy, addresses the implications of the latest FDA DTC guidance.
-
Type: PDF Pages: 16 Size: 4.4MB May 13, 2009An Eye on Google
Re-Engaging with Digital Marketing in Response to Recent FDA Warnings
Do recent FDA actions shut the door on paid search for pharmaceutical marketers? Sara Weiner, Senior Manager for Interactive Strategy, addresses the implications of the latest rulings.
-
Type: PDF Pages: 11 Size: 516KB April 1, 2009An Rx For What’s Next
Pharma Marketing During the Downturn and Beyond
The economic downturn has left consumers feeling betrayed and skeptical. Swen Graham, Senior Analyst for Strategy & Insights, analyzes spending, cultural and value trends to develop actionable thinking for pharmaceutical marketers. It’s essential reading as you forge into the uncharted waters of 2009 and beyond.